Huhtamaki India (509820) Q4 2020 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2020 earnings summary
27 Oct, 2026Executive summary
FY2020 revenue from operations was Rs. 24,627.0 mn, down 5.2% YoY; EBITDA fell 22% to Rs. 2,416.4 mn and PAT fell 43.5% to Rs. 959.9 mn, amid COVID-19 disruption and weaker product mix.
Essential-supply-chain operations continued under COVID protocols; priorities included sustainable packaging, manufacturing productivity, automation and digitalisation.
Financial highlights
Revenue from operations: Rs. 24,627.0 mn vs Rs. 25,989.8 mn in 2019; reported YoY decline 5.2%.
EBITDA: Rs. 2,416.4 mn vs Rs. 3,096.4 mn; EBIT: Rs. 1,437.1 mn vs Rs. 2,227.1 mn.
PAT: Rs. 959.9 mn vs Rs. 1,700.4 mn; EPS: Rs. 12.71 vs Rs. 22.52.
Operating cash flow was Rs. 1,693.4 mn vs Rs. 2,845.2 mn; capex was Rs. 1,231.8 mn.
Outlook and guidance
2021 priorities: improve cost competitiveness, optimise the manufacturing footprint, reduce waste, drive end-to-end productivity and implement zero-based budgeting.
Growth plans emphasised scaling core businesses, expanding in emerging markets, advancing sustainable packaging and food-delivery solutions, and investing in automation and expansion.
Industry outlook cited recovery in FMCG as markets stabilise and continued growth in e-commerce, hygiene, healthcare and pharmaceutical packaging.
Latest events from Huhtamaki India
- Q3 net sales rose 23.7%, while a Rs. 96 million restructuring charge cut PAT 19.1%.509820
Q3 2026 - Revenue rose 9% as EBIT surged 45.8%, while gross debt fell 32%.509820
Q4 2019 - Sales grew, but inflation, VRS costs and working capital drove a loss and higher debt.509820
Q4 2021 - Land-sale gains lifted PAT as operating margins improved despite lower revenue.509820
Q4 2023 - Sales grew, but costs and depreciation pressured earnings as new capacity came onstream.509820
Q4 2007 - Core sales grew 33%, while price pressure and higher interest weighed on FY97.509820
Q4 96/97 - Sales and volume advanced, but higher costs and price pressure cut FY 1997-98 profit.509820
Q4 97/98 - Profit rebounded as expansion and Van Leer funding met persistent pricing and input-cost pressure.509820
Q4 98/99 - Sales grew 12.2% in 2000, but input inflation and weak H2 demand squeezed margins.509820
Q4 2000